Skip to main content
Erschienen in: Community Mental Health Journal 2/2014

01.02.2014 | Original Paper

Community Child Psychiatric Medication Experiences Measured by an Internet-Based, Prospective Parent Survey of Retail Pharmacy Customers

verfasst von: Robert Hilt, Christine Wolf, Kent Koprowicz, Elizabeth Thomas, Mary Chandler, Xiao Lei Hao, Matthew Russell, Tung Le, Lee Hooks, Bryan King

Erschienen in: Community Mental Health Journal | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

One thousand five hundred parents filling a psychiatric prescription for their 6–18 year old child with a multi-state retail pharmacy chain received a single mailed invitation to complete a detailed online survey. 276 parents responded (18.4 %). 60 % of children on medications had a parent rated CBCL scale score in the clinically significant range at enrollment (T score ≥65), with a similar frequency of clinically significant CBCL scores through 15 months of survey followup. 47 % of medication regimens were noted to be causing persistent side effects. This simple community based data collection method can offer a unique way to investigate naturalistic treatment outcomes.
Literatur
Zurück zum Zitat Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families. Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families.
Zurück zum Zitat Benson, K., & Hartz, A. J. (2000). A comparison of observational studies and randomized, controlled trials. New England Journal of Medicine, 342(25), 1878–1886.PubMedCrossRef Benson, K., & Hartz, A. J. (2000). A comparison of observational studies and randomized, controlled trials. New England Journal of Medicine, 342(25), 1878–1886.PubMedCrossRef
Zurück zum Zitat Berk, M., Ng, F., Dodd, S., Callally, T., Campbell, S., Bernardo, M., et al. (2008). The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. Journal of Evaluation in Clinical Practice, 14(6), 979–983.PubMedCrossRef Berk, M., Ng, F., Dodd, S., Callally, T., Campbell, S., Bernardo, M., et al. (2008). The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. Journal of Evaluation in Clinical Practice, 14(6), 979–983.PubMedCrossRef
Zurück zum Zitat Brown, K. (2003). Psychopharmacology. The medication merry-go-round. Science, 299(5613), 1646–1649.PubMedCrossRef Brown, K. (2003). Psychopharmacology. The medication merry-go-round. Science, 299(5613), 1646–1649.PubMedCrossRef
Zurück zum Zitat Correll, C. U. (2008). Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 47(1), 9–20.PubMedCrossRef Correll, C. U. (2008). Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 47(1), 9–20.PubMedCrossRef
Zurück zum Zitat Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs (Millwood), 28(5), w770–w781.CrossRef Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs (Millwood), 28(5), w770–w781.CrossRef
Zurück zum Zitat Guy, W. (1976). ECDEU assessment manual for psychopharmacology. U.S. Department of Health, Education, and Welfare, 217–222. Guy, W. (1976). ECDEU assessment manual for psychopharmacology. U.S. Department of Health, Education, and Welfare, 217–222.
Zurück zum Zitat Leong, F., & Austin, J. T. (2005). The psychology research handbook: A guide for graduate students and research assistants (2nd ed.). Thousand Oaks, CA: Sage. Leong, F., & Austin, J. T. (2005). The psychology research handbook: A guide for graduate students and research assistants (2nd ed.). Thousand Oaks, CA: Sage.
Zurück zum Zitat NASMHPD. (2001). Technical report on psychiatric polypharmacy. Alexandria, VA: National Association of State Mental Health Program Directors Council. NASMHPD. (2001). Technical report on psychiatric polypharmacy. Alexandria, VA: National Association of State Mental Health Program Directors Council.
Zurück zum Zitat Raghavan, R., Zima, B. T., Andersen, R. M., Leibowitz, A. A., Schuster, M. A., & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15(1), 97–106.PubMedCrossRef Raghavan, R., Zima, B. T., Andersen, R. M., Leibowitz, A. A., Schuster, M. A., & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15(1), 97–106.PubMedCrossRef
Zurück zum Zitat Roberts, R., Rodriguez, W., Murphy, D., & Crescenzi, T. (2003). Pediatric drug labeling: Improving the safety and efficacy of pediatric therapies. Journal of the American Medical Association, 290(7), 905–911.PubMedCrossRef Roberts, R., Rodriguez, W., Murphy, D., & Crescenzi, T. (2003). Pediatric drug labeling: Improving the safety and efficacy of pediatric therapies. Journal of the American Medical Association, 290(7), 905–911.PubMedCrossRef
Zurück zum Zitat Safer, D. J., Zito, J. M., & DosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160(3), 438–449.PubMedCrossRef Safer, D. J., Zito, J. M., & DosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160(3), 438–449.PubMedCrossRef
Zurück zum Zitat Sahlqvist, S., Song, Y., Bull, F., Adams, E., Preston, J., Ogilvie, D., et al. (2011). Effect of questionnaire length, personalization and reminder type on response rate to a complex postal survey: Randomized controlled trial. BMC Medical Research Methodology, 11(62), 1–8. Sahlqvist, S., Song, Y., Bull, F., Adams, E., Preston, J., Ogilvie, D., et al. (2011). Effect of questionnaire length, personalization and reminder type on response rate to a complex postal survey: Randomized controlled trial. BMC Medical Research Methodology, 11(62), 1–8.
Zurück zum Zitat Shih, T., & Fan, X. (2008). Comparing response rates from web and mail surveys: A meta-analysis. Field Methods, 3, 249–271.CrossRef Shih, T., & Fan, X. (2008). Comparing response rates from web and mail surveys: A meta-analysis. Field Methods, 3, 249–271.CrossRef
Zurück zum Zitat Sprague, S., McKay, P., & Thoma, A. (2008). Study design and hierarchy of evidence for surgical decision making. Clinics in Plastic Surgery, 35(2), 195–205.PubMedCrossRef Sprague, S., McKay, P., & Thoma, A. (2008). Study design and hierarchy of evidence for surgical decision making. Clinics in Plastic Surgery, 35(2), 195–205.PubMedCrossRef
Zurück zum Zitat US Bureau of the Census. (2003). Statistical abstract of the United States. US Bureau of the Census. (2003). Statistical abstract of the United States.
Zurück zum Zitat Walton, S. M., Schumock, G. T., Lee, K. V., Alexander, G. C., Meltzer, D., & Stafford, R. S. (2008). Prioritizing future research on off-label prescribing: Results of a quantitative evaluation. Pharmacotherapy, 28(12), 1443–1452.PubMedCrossRef Walton, S. M., Schumock, G. T., Lee, K. V., Alexander, G. C., Meltzer, D., & Stafford, R. S. (2008). Prioritizing future research on off-label prescribing: Results of a quantitative evaluation. Pharmacotherapy, 28(12), 1443–1452.PubMedCrossRef
Zurück zum Zitat Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2(24), 1–11. Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2(24), 1–11.
Metadaten
Titel
Community Child Psychiatric Medication Experiences Measured by an Internet-Based, Prospective Parent Survey of Retail Pharmacy Customers
verfasst von
Robert Hilt
Christine Wolf
Kent Koprowicz
Elizabeth Thomas
Mary Chandler
Xiao Lei Hao
Matthew Russell
Tung Le
Lee Hooks
Bryan King
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Community Mental Health Journal / Ausgabe 2/2014
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-013-9671-x

Weitere Artikel der Ausgabe 2/2014

Community Mental Health Journal 2/2014 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.